Citronellal improves ischemia-induced pathological senescence of hippocampal neurons and cognitive impairment via regulation of the TRPM2/NMDAR pathway.
Abstract
Vascular dementia (VaD) is associated with chronic cerebral hypoperfusion, oxidative stress, mitochondrial dysfunction, and hippocampal neuronal senescence. Citronellal (CT) ameliorates cognitive impairment in 2VO-induced VaD rats. CT improved spatial learning and working memory, reduced in vivo oxidative stress, restored hippocampal dendritic spine density, upregulated hippocampal myelin basic protein (MBP), and decreased P-p53, p21, and SA-β-gal. CT also restored mitochondrial membrane potential and reduced Drp1/FIS1 expression. Mechanistically, CT suppressed TRPM2 and restored NMDAR1; TRPM2 deficiency weakened CT-mediated NMDAR1 regulation. These findings suggest that CT ameliorates VaD-related cognitive impairment by inhibiting hippocampal aging through TRPM2/NMDAR-associated oxidative stress-mitochondrial pathways.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Citronellal ameliorates cognitive impairment in vascular dementia by regulating the TRPM2/NMDAR pathway and reducing hippocampal aging. The paper addresses mechanisms related to neuronal senescence and cognitive decline, which are directly tied to aging processes.
Author of this paper? Send a correction.